Informed Consent for Antineoplastics and Biologics for Non-Onc Indications

PLEASE NOTE:   Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP). 

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jrufo@ismp.org. 

1 post / 0 new
Log in or register to post comments
Wed, 08/21/2024 - 14:59
#1
Francesca Mernick
Francesca Mernick's picture
Offline
Last seen: 1 month 2 weeks ago
Joined: 07/25/2019 - 16:59
Informed Consent for Antineoplastics and Biologics for Non-Onc Indications

Hello!

We are interested in learning whether your sites require written informed consent for antineoplastics and biologics when used for non-oncology indications in the outpatient infusion setting (i.e. rituximab or infliximab for rheumatoid arthritis).

If yes, do you employ an electronic process for documenting informed consent?

Thank you!
Frankie

Top